Wealth Enhancement Advisory Services LLC Increases Stock Position in BlackRock Science and Technology Term Trust $BSTZ

Wealth Enhancement Advisory Services LLC boosted its position in shares of BlackRock Science and Technology Term Trust (NASDAQ:BSTZ) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 204,880 shares of the company’s stock after purchasing an additional 24,439 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in BlackRock Science and Technology Term Trust were worth $4,698,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Amplius Wealth Advisors LLC lifted its holdings in BlackRock Science and Technology Term Trust by 2.8% in the 3rd quarter. Amplius Wealth Advisors LLC now owns 17,990 shares of the company’s stock worth $399,000 after buying an additional 494 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of BlackRock Science and Technology Term Trust by 13.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 6,638 shares of the company’s stock valued at $138,000 after acquiring an additional 767 shares in the last quarter. Merit Financial Group LLC increased its position in shares of BlackRock Science and Technology Term Trust by 7.6% during the third quarter. Merit Financial Group LLC now owns 11,938 shares of the company’s stock worth $265,000 after acquiring an additional 847 shares during the last quarter. Stablepoint Partners LLC lifted its stake in shares of BlackRock Science and Technology Term Trust by 8.3% in the third quarter. Stablepoint Partners LLC now owns 12,211 shares of the company’s stock worth $271,000 after acquiring an additional 941 shares in the last quarter. Finally, SeaCrest Wealth Management LLC lifted its stake in shares of BlackRock Science and Technology Term Trust by 4.7% in the third quarter. SeaCrest Wealth Management LLC now owns 23,556 shares of the company’s stock worth $540,000 after acquiring an additional 1,063 shares in the last quarter.

Insider Activity at BlackRock Science and Technology Term Trust

In related news, Portfolio Manager Tony Kim purchased 41,825 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was acquired at an average price of $22.00 per share, with a total value of $920,150.00. Following the completion of the transaction, the portfolio manager owned 251,554 shares of the company’s stock, valued at $5,534,188. This represents a 19.94% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

BlackRock Science and Technology Term Trust Price Performance

Shares of BSTZ opened at $21.21 on Tuesday. BlackRock Science and Technology Term Trust has a one year low of $15.22 and a one year high of $23.47. The stock has a 50-day moving average price of $22.36 and a 200 day moving average price of $22.36.

BlackRock Science and Technology Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be given a $0.1625 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 9.2%. The ex-dividend date of this dividend is Monday, June 15th.

BlackRock Science and Technology Term Trust Company Profile

BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.

The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.